Selected News & Events
Stealth BioTherapeutics Presents New SBT-272 Data Demonstrating Improvement in Upper Motor Neuron Function in ALS Disease Model at Keystone Neurodegeneration Symposium
Stealth BioTherapeutics Receives Orphan Drug Designation from the European Medicines Agency for Elamipretide for the Treatment of Myopathic Mitochondrial DNA Depletion Syndrome
Stealth BioTherapeutics Announces Data from the Phase 2 ReCLAIM-2 Study of Elamipretide in Geographic Atrophy at the Clinical Trials at the Summit Meeting 2022
Stealth BioTherapeutics Receives Orphan Drug Designation from FDA for Elamipretide for Treatment of Duchenne Muscular Dystrophy
Events Calendar
No events listed at this time.
@StealthBT on Twitter
We are just a week away from the 2025 Mito Town Meeting. We have so many wonderful people from our mito community coming to present on what they accomplished in 2024 and what they have in store for 2025. Register on our website to join us next Friday! https://buff.ly/3Dmerec
#BarthSyndrome is a #RareDisease that affects the muscles, and can lead to serious heart problems, debilitating fatigue, lack of appetite, growth delays, and more. It impacts all aspects of life. To learn more about this condition, listen to Abe’s story.
Contact Us
Stealth BioTherapeutics
275 Grove Street, Suite 3-107
Newton, MA 02466
(617) 600-6888
info@stealthbt.com